CN104922735B - 一种药物球囊的制备方法 - Google Patents
一种药物球囊的制备方法 Download PDFInfo
- Publication number
- CN104922735B CN104922735B CN201510354380.3A CN201510354380A CN104922735B CN 104922735 B CN104922735 B CN 104922735B CN 201510354380 A CN201510354380 A CN 201510354380A CN 104922735 B CN104922735 B CN 104922735B
- Authority
- CN
- China
- Prior art keywords
- medicine
- sacculus
- particulate coatings
- coatings
- drug solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 131
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- 238000000576 coating method Methods 0.000 claims abstract description 91
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 20
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011780 sodium chloride Substances 0.000 claims abstract description 10
- 239000002245 particle Substances 0.000 claims abstract description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 8
- 239000004202 carbamide Substances 0.000 claims abstract description 7
- 239000001110 calcium chloride Substances 0.000 claims abstract description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims description 64
- 239000000243 solution Substances 0.000 claims description 48
- 239000011248 coating agent Substances 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 229930012538 Paclitaxel Natural products 0.000 claims description 17
- 229960001592 paclitaxel Drugs 0.000 claims description 17
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 238000002425 crystallisation Methods 0.000 claims description 10
- 230000008025 crystallization Effects 0.000 claims description 10
- 238000005507 spraying Methods 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 6
- 230000000996 additive effect Effects 0.000 claims description 6
- 235000013877 carbamide Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 125000002456 taxol group Chemical group 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 3
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 3
- 229960002930 sirolimus Drugs 0.000 claims description 3
- 238000002604 ultrasonography Methods 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 12
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000000717 retained effect Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 208000037803 restenosis Diseases 0.000 description 5
- 238000011068 loading method Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000004531 microgranule Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012296 anti-solvent Substances 0.000 description 3
- 239000011247 coating layer Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000008215 water for injection Substances 0.000 description 3
- 244000050510 Cunninghamia lanceolata Species 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005167 everolimus Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000005077 saccule Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/10—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
Abstract
Description
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510354380.3A CN104922735B (zh) | 2015-06-24 | 2015-06-24 | 一种药物球囊的制备方法 |
PCT/CN2015/082452 WO2016206078A1 (zh) | 2015-06-24 | 2015-06-26 | 一种药物球囊的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510354380.3A CN104922735B (zh) | 2015-06-24 | 2015-06-24 | 一种药物球囊的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104922735A CN104922735A (zh) | 2015-09-23 |
CN104922735B true CN104922735B (zh) | 2017-03-22 |
Family
ID=54110374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510354380.3A Active CN104922735B (zh) | 2015-06-24 | 2015-06-24 | 一种药物球囊的制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN104922735B (zh) |
WO (1) | WO2016206078A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021022799A1 (zh) * | 2019-08-02 | 2021-02-11 | 上海心玮医疗科技股份有限公司 | 一种药物代谢可控的药物球囊及其制备方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106620887B (zh) * | 2016-11-03 | 2019-12-03 | 上海申淇医疗科技有限公司 | 一种药物球囊的生产方法 |
CN106798951B (zh) * | 2017-02-24 | 2020-03-10 | 浙江巴泰医疗科技有限公司 | 一种药物洗脱球囊的制备方法 |
CN107362439B (zh) * | 2017-08-14 | 2020-09-01 | 乐普(北京)医疗器械股份有限公司 | 一种药物涂层球囊导管的制备方法、制备得到的药物涂层球囊导管及其应用 |
CN107754022A (zh) * | 2017-11-10 | 2018-03-06 | 辽宁垠艺生物科技股份有限公司 | 一种药物涂层及其制备方法 |
CN114788898A (zh) * | 2022-04-15 | 2022-07-26 | 杭州巴泰医疗器械有限公司 | 一种冠脉球囊表面结晶药物涂层的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103830778A (zh) * | 2012-11-23 | 2014-06-04 | 上海微创医疗器械(集团)有限公司 | 一种含有聚电解质的药物涂层及其制备方法 |
CN104174074A (zh) * | 2013-11-27 | 2014-12-03 | 浙江归创医疗器械有限公司 | 一种药物涂层组合物、其制备方法及利用其制成的植入或介入医疗器械 |
CN104623740A (zh) * | 2013-11-15 | 2015-05-20 | 微创心脉医疗科技(上海)有限公司 | 一种药物球囊及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
US6923996B2 (en) * | 2003-05-06 | 2005-08-02 | Scimed Life Systems, Inc. | Processes for producing polymer coatings for release of therapeutic agent |
DE102012200077A1 (de) * | 2012-01-04 | 2013-07-18 | Cortronik GmbH | Ballonkatheter mit einer aktiven Beschichtung |
CN104174073B (zh) * | 2014-08-27 | 2016-07-06 | 辽宁生物医学材料研发中心有限公司 | 一种药物洗脱球囊导管的载药方法 |
CN104353132B (zh) * | 2014-11-21 | 2016-05-18 | 浙江归创医疗器械有限公司 | 一种植入或介入医疗器械上药物涂层的涂覆工艺 |
CN104511084A (zh) * | 2014-12-30 | 2015-04-15 | 深圳市信立泰生物医疗工程有限公司 | 一种球囊导管 |
-
2015
- 2015-06-24 CN CN201510354380.3A patent/CN104922735B/zh active Active
- 2015-06-26 WO PCT/CN2015/082452 patent/WO2016206078A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103830778A (zh) * | 2012-11-23 | 2014-06-04 | 上海微创医疗器械(集团)有限公司 | 一种含有聚电解质的药物涂层及其制备方法 |
CN104623740A (zh) * | 2013-11-15 | 2015-05-20 | 微创心脉医疗科技(上海)有限公司 | 一种药物球囊及其制备方法 |
CN104174074A (zh) * | 2013-11-27 | 2014-12-03 | 浙江归创医疗器械有限公司 | 一种药物涂层组合物、其制备方法及利用其制成的植入或介入医疗器械 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021022799A1 (zh) * | 2019-08-02 | 2021-02-11 | 上海心玮医疗科技股份有限公司 | 一种药物代谢可控的药物球囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104922735A (zh) | 2015-09-23 |
WO2016206078A1 (zh) | 2016-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104922735B (zh) | 一种药物球囊的制备方法 | |
CN106237395B (zh) | 一种药物涂层球囊及其制备方法 | |
US9724497B2 (en) | Method of coating a catheter balloon having a fold | |
KR101858267B1 (ko) | 활성물질을 방출하는 입자 불함유 코팅을 갖는 의약제품 | |
CN106620887B (zh) | 一种药物球囊的生产方法 | |
CN105517536B (zh) | 可注射的持续释放组合物及其用于治疗关节炎症及相关疼痛的方法 | |
CN106237485A (zh) | 一种药物涂层球囊扩张导管及其制备方法 | |
JP6174038B2 (ja) | 薬剤被覆された医療機器およびその調整方法 | |
US10064981B2 (en) | Catheter with drug coating | |
CN104984412A (zh) | 一种药物球囊表面紫杉醇涂层的制备方法 | |
CN103566415A (zh) | 一种双面涂层的人体血管植入物及其制作方法 | |
US11013832B2 (en) | Formulations for tailored drug release | |
CN206604008U (zh) | 一种药物涂层球囊扩张导管 | |
CN107106506A (zh) | 用于治疗剂的超局部化释放的可注射微粒 | |
CN107496998B (zh) | 外周药物洗脱支架及其制备和应用 | |
CN106727414A (zh) | 一种甲磺酸达比加群酯微丸及制备方法 | |
CN106798951B (zh) | 一种药物洗脱球囊的制备方法 | |
Pruessmann et al. | Influence of dissolution vessel geometry and dissolution medium on in vitro dissolution behaviour of triamterene-coated model stents in different test setups | |
CN103565564B (zh) | 一种含磁性底层的双面涂层药物洗脱支架及其制作方法 | |
CN106730045A (zh) | 一种药物涂层组合物及其制备方法 | |
Auel et al. | The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms. Pharmaceutics 2021, 13, 1394 | |
CN115025292B (zh) | 一种药物涂层、药物涂层球囊及其制备方法 | |
CN106924812A (zh) | 一种药物缓释支架及其制备方法和应用 | |
JP6567716B1 (ja) | 生分解性マイクロニードルアレイ | |
Eck | TUNABLE DUAL-PHASE DUAL-DRUG DELIVERY SYSTEM USING A PLGA MICROPARTICLE/PVA HYDROGEL COMPOSITE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151221 Address after: 310018, Zhejiang, Hangzhou economic and Technological Development Zone, No. 20, No. 1, building 2, South District, No. 2 Applicant after: ZHEJIANG BATAI MEDICAL TECHNOLOGY CO., LTD. Address before: 311121, Yuhang District, Zhejiang province Hangzhou Jing Long Village One Village talent apartment 1, unit 2, 501 Applicant before: Yan Yuqiang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for manufacturing medicine balloons Effective date of registration: 20200325 Granted publication date: 20170322 Pledgee: China Minsheng Banking Corp Hangzhou branch Pledgor: ZHEJIANG BATAI MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020330000120 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210929 Granted publication date: 20170322 Pledgee: China Minsheng Bank Co., Ltd. Hangzhou Branch Pledgor: Zhejiang Batai Medical Technology Co., Ltd Registration number: Y2020330000120 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of drug balloon Effective date of registration: 20220401 Granted publication date: 20170322 Pledgee: Hangzhou United Rural Commercial Bank Limited by Share Ltd. Development Zone sub branch Pledgor: ZHEJIANG BATAI MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2022980003788 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |